Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 23

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 23
---
 Directors could adopt a “poison pill” which would, under certain circumstances
related to an acquisition of our securities that is not approved by the Board of Directors, give certain holders the right to acquire
additional shares of our common stock at a low price. The Board of Directors also could strategically sell shares of common stock in a
private transaction to purchasers who would oppose a takeover or favor the current Board of Directors. Although this Proposal 1 has been
prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board of Directors
currently aware of any such attempts directed at us), stockholders should be aware that approval of this Proposal 1 could facilitate future
efforts by us to deter or prevent changes in control, including transactions in which the stockholders might otherwise receive a premium
for their shares over then current market prices.

| 12 |

Effects of Reverse Stock Split

After the effective time of a Reverse Stock Split
(if approved by the stockholders and implemented by our Board of Directors), each stockholder will own a reduced number of shares of common
stock as compared to immediately prior to the effective time of the Reverse Stock Split. However, any Reverse Stock Split that is implemented
by our Board of Directors would affect all of our stockholders uniformly and would not affect any stockholder’s percentage ownership
interests in the Company, except for adjustments that may result from the treatment of fractional shares as described below. Voting rights
and other rights and preferences of the holders of our common stock will not be affected by a Reverse Stock Split (other than for adjustments
that may result from the treatment of fractional shares as described below). For example, a holder of 2% of the voting power of the outstanding
shares of our common stock immediately prior to a Reverse Stock Split would continue to hold 2% (assuming there is no impact as a result
of the treatment of fractional shares as described below) of the voting power of the outstanding shares of our common stock immediately
after such Reverse Stock Split. The number of stockholders of record will not be affected by a Reverse Stock Split.

The principal effects of a Reverse
Stock Split that is implemented by our Board of Directors will be that:

| · | depending on the Reverse Stock Split ratio selected by the Board of Directors, each eight to 12 shares of our common stock owned by a stockholder will be combined into one post-split share of our common stock;                                                                                                                                                                                                                                                                                                                                                                                           |
| · | no fractional shares of common stock